Hi Shelbee, Lenalidomide is, I’ve read, the most effective myeloma drug so far. Like all myeloma drugs it works for more of us, for longer, than other individual myeloma drugs.
In some USA centres SCT is now rarely if ever recommended as US patients have access to more personalised drug combinations and the latest approved drugs which are not yet available for NHS patients. However in UK SCT is still the standard protocol for fit enough patients (most under 70s & some over 70s) because this is the way to keep the disease inactive or stable for a longer period than without it, (now that lenalidomide maintenance is available on NHS the average time until another treatment is necessary is 60 months, 5 years. ) I presume that your husband still has signs of myeloma being active otherwise he would not be needing chemotherapy before going in to hospital for SCT, so it’s unlikely that lenalidomide alone would provide your husband with years of inactive disease, and it’s for patients like this that SCT has a clearer benefit (for me it seemed to reset the immune system) but other good drugs are now available. He should check with his consultant whether he will later be eligible for daratumumab, velcade & dexamethazone (DVD) which seems to be being very effective. SCT isn’t really a straightforward choice and your husbands concerns about SCT are perfectly valid, (although some of us have much easier experiences than we expect) but his worry about pre SCT does not match my experience. I had a cyclophosphamide infusion as my myeloma was still active. This took a total of 2 or 3 hours in hospital, after which I drove straight away to another hospital as my mother had been admitted in an emergency & I hardly had time to think about it. The cyclophosphamide had no side effects, except I lost my hair 2 weeks later.